308 related articles for article (PubMed ID: 31738935)
1. Ginsenoside Rg1 protects mice against streptozotocin-induced type 1 diabetic by modulating the NLRP3 and Keap1/Nrf2/HO-1 pathways.
Gao Y; Li J; Chu S; Zhang Z; Chen N; Li L; Zhang L
Eur J Pharmacol; 2020 Jan; 866():172801. PubMed ID: 31738935
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg1 attenuates lipopolysaccharide-induced chronic liver damage by activating Nrf2 signaling and inhibiting inflammasomes in hepatic cells.
Zhou H; Liu Y; Su Y; Ji P; Kong L; Sun R; Zhang D; Xu H; Li W; Li W
J Ethnopharmacol; 2024 Apr; 324():117794. PubMed ID: 38244950
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg1 Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury via Activation of Nrf2/HO-1 Signaling and Inhibition of JNK.
Li Q; Xiang Y; Chen Y; Tang Y; Zhang Y
Cell Physiol Biochem; 2017; 44(1):21-37. PubMed ID: 29130959
[TBL] [Abstract][Full Text] [Related]
5. Hepatoprotective effect of ginsenoside Rg1 from Panax ginseng on carbon tetrachloride-induced acute liver injury by activating Nrf2 signaling pathway in mice.
Ning C; Gao X; Wang C; Huo X; Liu Z; Sun H; Yang X; Sun P; Ma X; Meng Q; Liu K
Environ Toxicol; 2018 Oct; 33(10):1050-1060. PubMed ID: 29964319
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg1 alleviates acute liver injury through the induction of autophagy and suppressing NF-κB/NLRP3 inflammasome signaling pathway.
Zhao J; He B; Zhang S; Huang W; Li X
Int J Med Sci; 2021; 18(6):1382-1389. PubMed ID: 33628094
[No Abstract] [Full Text] [Related]
7. Caffeic acid prevents acetaminophen-induced liver injury by activating the Keap1-Nrf2 antioxidative defense system.
Pang C; Zheng Z; Shi L; Sheng Y; Wei H; Wang Z; Ji L
Free Radic Biol Med; 2016 Feb; 91():236-46. PubMed ID: 26721592
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg1 Protects against Non-alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation.
Xu Y; Yang C; Zhang S; Li J; Xiao Q; Huang W
Biol Pharm Bull; 2018 Nov; 41(11):1638-1644. PubMed ID: 30135326
[TBL] [Abstract][Full Text] [Related]
9. Irbesartan ameliorates diabetic nephropathy by activating the Nrf2/Keap1 pathway and suppressing NLRP3 inflammasomes in vivo and in vitro.
Li Y; Long W; Zhang H; Zhao M; Gao M; Guo W; Yu L
Int Immunopharmacol; 2024 Apr; 131():111844. PubMed ID: 38503013
[TBL] [Abstract][Full Text] [Related]
10. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
[TBL] [Abstract][Full Text] [Related]
11. Keap1/Nrf2/HO-1 signaling pathway contributes to p-chlorodiphenyl diselenide antidepressant-like action in diabetic mice.
Zborowski VA; Heck SO; Vencato M; Pinton S; Marques LS; Nogueira CW
Psychopharmacology (Berl); 2020 Feb; 237(2):363-374. PubMed ID: 31828396
[TBL] [Abstract][Full Text] [Related]
12. Formononetin, a bioactive isoflavonoid constituent from Astragalus membranaceus (Fisch.) Bunge, ameliorates type 1 diabetes mellitus via activation of Keap1/Nrf2 signaling pathway: An integrated study supported by network pharmacology and experimental validation.
Chen H; Lou Y; Lin S; Tan X; Zheng Y; Yu H; Jiang R; Wei Y; Huang H; Qi X; Zhang R; Liu Z; Wu J
J Ethnopharmacol; 2024 Mar; 322():117576. PubMed ID: 38104880
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Nrf2/HO-1 signaling leads to increased activation of the NLRP3 inflammasome in osteoarthritis.
Chen Z; Zhong H; Wei J; Lin S; Zong Z; Gong F; Huang X; Sun J; Li P; Lin H; Wei B; Chu J
Arthritis Res Ther; 2019 Dec; 21(1):300. PubMed ID: 31870428
[TBL] [Abstract][Full Text] [Related]
14. Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis.
Ai G; Huang R; Xie J; Zhong L; Wu X; Qin Z; Su Z; Chen J; Yang X; Dou Y
J Ethnopharmacol; 2023 Jan; 301():115775. PubMed ID: 36198377
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg1 protects against acetaminophen-induced liver injury via activating Nrf2 signaling pathway in vivo and in vitro.
Ning C; Gao X; Wang C; Kong Y; Liu Z; Sun H; Sun P; Huo X; Ma X; Meng Q; Liu K
Regul Toxicol Pharmacol; 2018 Oct; 98():58-68. PubMed ID: 30030101
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant activities of ginsenoside Rg1 against cisplatin-induced hepatic injury through Nrf2 signaling pathway in mice.
Gao Y; Chu S; Shao Q; Zhang M; Xia C; Wang Y; Li Y; Lou Y; Huang H; Chen N
Free Radic Res; 2017 Jan; 51(1):1-13. PubMed ID: 27931128
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the Keap1/Nrf2 Signaling Pathway Significantly Promotes the Progression of Type 1 Diabetes Mellitus.
Lou Y; Kong M; Li L; Hu Y; Zhai W; Qi X; Liu Z; Wu J
Oxid Med Cell Longev; 2021; 2021():7866720. PubMed ID: 33628382
[TBL] [Abstract][Full Text] [Related]
18. Diosmetin alleviates cerebral ischemia-reperfusion injury through Keap1-mediated Nrf2/ARE signaling pathway activation and NLRP3 inflammasome inhibition.
Shi M; Wang J; Bi F; Bai Z
Environ Toxicol; 2022 Jun; 37(6):1529-1542. PubMed ID: 35191607
[TBL] [Abstract][Full Text] [Related]
19. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
Lv C; Cheng T; Zhang B; Sun K; Lu K
Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
[No Abstract] [Full Text] [Related]
20. Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.
Du L; Wang J; Chen Y; Li X; Wang L; Li Y; Jin X; Gu X; Hao M; Zhu X; Yin X; Lu Q
Cell Biol Toxicol; 2020 Jun; 36(3):243-260. PubMed ID: 31768838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
